PMID,Title,Journal,Year
29737503,A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials.,Drug safety,2018
23254906,Which are the antibodies to watch in 2013?,mAbs,2013
